Moberg Pharma AB (Formerly known as Moberg Derma) Year-end Report 2014
Regulatory News:
Moberg Pharma AB (STO:MOB)
SUCCESSFUL FOURTH QUARTER AND THE FIRST PROFITABLE FULL YEAR
PERIOD (JAN-DEC 2014)
ยท Revenue MSEK 200.2 (157.4)
Help employers find you! Check out all the jobs and post your resume.
Moberg Pharma AB (STO:MOB)
SUCCESSFUL FOURTH QUARTER AND THE FIRST PROFITABLE FULL YEAR
PERIOD (JAN-DEC 2014)
ยท Revenue MSEK 200.2 (157.4)
Help employers find you! Check out all the jobs and post your resume.